- Advertisement -
Clinuvel Pharmaceuticals Ltd (ASX: CUV) shares were out of form on Friday.
The ASX All Ords stock ended the week with a 10% decline to $10.01.
This leaves the biopharmaceutical company’s shares trading close to a 52-week low.
While this is disappointing, the team at Bell Potter believes it has…
